Outpatient Surgery Fee Schedule

Total Page:16

File Type:pdf, Size:1020Kb

Outpatient Surgery Fee Schedule OUTPATIENT SURGERY FEE SCHEDULE PROC DESCRIPTION 2010 Rate 2011 Rate 2012 Rate 10021 FINE NEEDLE ASPIRATION;W/O IMAGING GUIDE $27.11 $27.11 $27.11 10022 FINE NEEDLE ASPIREATION;W/IMAGING GUIDE $36.34 $36.34 $36.34 10040 ACNE SURG(E.G.MARSUPIALIZATION)OPN-REMOV $822.23 $822.23 $822.23 10060 INCIS&DRAIN ABCESS/CYST, SIMPLE/SINGLE $822.23 $822.23 $822.23 10061 INCIS&DRAIN CYST/ABSESS COMPLICA/MULTIPL $822.23 $822.23 $822.23 10080 I&D PILONIDAL CYST SIMPLE $822.23 $822.23 $822.23 10081 I&D PILONIDAL CYST COMPLICATED $822.23 $822.23 $822.23 10120 INC REMOVAL FOREIGN BODY SURG SIMPLE $822.23 $822.23 $822.23 10121 INC REMOVAL FOREIGN BODY SURG COMPLICAT $822.23 $822.23 $822.23 10140 I&D HEMATOMA, SEROMA OR FLUID COLLECTION $822.23 $822.23 $822.23 10160 PUNCT ASPLE ABSCESS HEMATOMA BULLA CYST $125.00 $125.00 $125.00 10180 INCISION/DRAINAGE,COMPLEX,POSTOP WOUND. $822.23 $822.23 $822.23 11000 DEBRI EXTEN ECZEMA OR INFECT SKIN 10% $570.00 $570.00 $570.00 11004 DEBRI SKIN,SUBCUT TIS,EXT GENTALIA&PERIN $822.23 $822.23 $822.23 11005 DEBRIDE SKIN,SUBCUTAN TIS,ABDOMINAL WALL $822.23 $822.23 $822.23 11006 DEBR SKN,SUBCUT TIS,EXT GENTAL,PERIN&ABD $822.23 $822.23 $822.23 11008 REMV PROSTH MATR'L/MESH,ABD WALL/ADD-ON $125.00 $125.00 $125.00 11010 DEBRID/OPEN FRACT-DISLOC;SKIN&SUBCU TISS $822.23 $822.23 $822.23 11011 DEBRID/OPN FRA&DISL;SKN,SUBCU,MUSCLE FAS $822.23 $822.23 $822.23 11012 DEBRID/OPN FRA&DISL;SKN,SUBC,MUS FAS,BON $822.23 $822.23 $822.23 11040 DEBRIDEMENT SKIN PARTIAL THICKNESS $1,339.05 D D 11041 DEBRIDEMENT SKIN FULL THICKNESS $1,339.05 D D 11042 DEBRIDEMENT SKIN AND SUBCUTANEOUS TISSUE $1,339.05 $1,339.05 $1,339.05 11043 DEBRIDEMENT SKIN SUBCUTAN TISSU MUSCLE $1,339.05 $1,339.05 $1,339.05 11044 DEBRIDEMENT SKIN SUBCUTAN TISS MUSC BONE $1,339.05 $1,339.05 $1,339.05 11045 DEBRIDEMNT,SUBCUT TISSUE;EA ADD 20 SQ Not Valid $1,339.05 $1,339.05 11046 DEBRID,MUSCL/FASC (EPID,DERMIS,SUBCU Not Valid $1,339.05 $1,339.05 11047 DEBRIDEMENT, BONE; EACH ADD'L 20 SQ CM Not Valid $1,339.05 $1,339.05 11055 PARING/CUT BEN HYPERKERATOTIC LESI;SINGL $822.23 $822.23 $822.23 11056 PARING/CUT BEN HYPERKERATOTIC LESI; 20R4 $822.23 $822.23 $822.23 11057 PARING/CUT BEN HYPERKERATOTIC LESINOS;4+ $822.23 $822.23 $822.23 11100 BIOPSY SKN SQ TSSUE MUCOS MEMBRANE 1 LES $822.23 $822.23 $822.23 11200 REMOV SKN TAGS MULT FIBROCUT 15 OR < LES $822.23 $822.23 $822.23 11300 SHVG EPID/DERML LESION SGL TK/AM/LG .5C< $822.23 $822.23 $822.23 11301 SHAVE SKIN LESION, DIA 6.5 TO 1.0 CM $822.23 $822.23 $822.23 11302 SHVG EPID/DRM LESION SGL TK/AM/LG 1.1-2C $822.23 $822.23 $822.23 11303 SHVG EPID/DERM LESION SGL TK/AM/LG 2.0>C $822.23 $822.23 $822.23 11305 SHV EPD/DRL LSN SGL SCL/NK/HD/FT/GT .5C< $822.23 $822.23 $822.23 11306 SHV EPD/DRM LSN SGL SCL/NK/HD/FT/G .6-1C $822.23 $822.23 $822.23 11307 SHV EPD/DRM LSN SGL SCL/NK/HD/F/G 1.1-2G $822.23 $822.23 $822.23 11308 SHV EPD/DRL LSN SGL SCL/NK/HD/FT/G 2.0C> $822.23 $822.23 $822.23 11310 SHV EPD/DRM LESION SGL F/E/E/N/L/MM .5C< $822.23 $822.23 $822.23 11311 SHV EPD/DRM LESN SGL F/E/E/N/L/MM .6-1C $822.23 $822.23 $822.23 11312 SHV EPD/DRM LSN SGL F/E/E/N/L/MM 1.1-2CM $822.23 $822.23 $822.23 11313 SHV EPD/DRM LSN SGL F/E/E/N/L/MM DIA 2C> $822.23 $822.23 $822.23 11400 EXC BENGN LES INCL MARG,T-A-L,<= 0.5 CM $822.23 $822.23 $822.23 07/27/12 Page 1 of 90 PROC DESCRIPTION 2010 Rate 2011 Rate 2012 Rate 11401 EXC BENGN LES INCL MARGIN,T-A-L,0.6-1 CM $822.23 $822.23 $822.23 11402 EXC BENGN LES INCL MARGIN,T-A-L,1.1-2 CM $822.23 $822.23 $822.23 11403 EXC BENGN LES INCL MARGIN,T-A-L,2.1-3 CM $822.23 $822.23 $822.23 11404 EXC BENGN LES INCL MARGIN,T-A-L,3.1-4 CM $822.23 $822.23 $822.23 11406 EXC BENGN LES INCL MARGIN,T-A-L, > 4.0CM $822.23 $822.23 $822.23 11420 EXC BENGN LES INCL MARG H-F-NK-SP 0.5 < $822.23 $822.23 $822.23 11421 EXC BENGN LES INCL MARG H-F-NK-SP 0.6-1 $822.23 $822.23 $822.23 11422 EXC BENGN LES INCL MARG H-F-NK-SP 1.1-2 $822.23 $822.23 $822.23 11423 EXC BENGN LES INCL MARG H-F-NK-SP 2.1-3 $822.23 $822.23 $822.23 11424 EXC BENGN LES INCL MARG H-F-NK-SP 3.1-4 $822.23 $822.23 $822.23 11426 EXC BENGN LES INCL MARG H-F-NK-SP > 4 CM $822.23 $822.23 $822.23 11440 EXC BEGN LES INCL MARG FACE 0.5 < CM $822.23 $822.23 $822.23 11441 EXC BEGN LES INCL MARG FACE 0.6-1 CM $822.23 $822.23 $822.23 11442 EXC BEGN LES INCL MARG FACE 1.1-2 CM $822.23 $822.23 $822.23 11443 EXC BEGN LES INCL MARG FACE 2.1-3 CM $822.23 $822.23 $822.23 11444 EXC BEGN LES INCL MARG FACE 3.1-4 CM $822.23 $822.23 $822.23 11446 EXC BEGN LES INCL MARG FACE > 4 CM $822.23 $822.23 $822.23 11450 EXC SKN SUBQ HIDRADENITIS AX SIM/INT REP $822.23 $822.23 $822.23 11451 EXC SKN SUBQ HIDRADENITIS AX COMPLEX REP $822.23 $822.23 $822.23 11462 EXC SKN SUBQ HIDRADENITIS ING SIM/INT RE $822.23 $822.23 $822.23 11463 EXC SKN SUBQ HIDRADENITIS ING COMPLEX RE $822.23 $822.23 $822.23 11470 EXCIS SKIN-SUBQ HIDRADENTIS PERI/NAL/NEA $822.23 $822.23 $822.23 11471 EXCIS SKIN-SUBQ HIDRADENITIS PERI/NAL/NE $822.23 $822.23 $822.23 11600 EXC MALGN LES INC MARG,TRNK-ARM-LG .5<CM $822.23 $822.23 $822.23 11601 EXC MALG LES INC MARG,TRNK-ARM-LG .6-1CM $822.23 $822.23 $822.23 11602 EXC MAL LES INC MAR,TRNK-ARM-LG 1.1-2 CM $822.23 $822.23 $822.23 11603 EXC MAL LES INC MAR,TRNK-ARM-LG 2.1-3 CM $822.23 $822.23 $822.23 11604 EXC MAL LES INC MAR,TRNK-ARM-LG 3.1-4 CM $822.23 $822.23 $822.23 11606 EXC MALG LES INC MAR,TRNK-ARM-LEG > 4CM $822.23 $822.23 $822.23 11620 EXC,MAL LES INC MAR,HND-FT-NK-SP 0.5 < $822.23 $822.23 $822.23 11621 EXC,MAL LES INC MAR,HND-FT-NK-SP 0.6-1 $822.23 $822.23 $822.23 11622 EXC,MAL LES INC MAR,HND-FT-NK-SP 1.1-2 $822.23 $822.23 $822.23 11623 EXC,MAL LES INC MAR,HND-FT-NK-SP 2.1-3 $822.23 $822.23 $822.23 11624 EXC,MAL LES INC MAR,HND-FT-NK-SP 3.1-4 $822.23 $822.23 $822.23 11626 EXC,MAL LES INC MAR,HND-FT-NK-SP > 4 CM $822.23 $822.23 $822.23 11640 EXCISE,MALIG LESION INCL MARG,FACE 0.5 < $822.23 $822.23 $822.23 11641 EXCISE,MALG LESION INCL MARG, FACE 0.6-1 $822.23 $822.23 $822.23 11642 EXCISE,MALG LESION INCL MARG, FACE 1.1-2 $822.23 $822.23 $822.23 11643 EXCISE,MALG LESION INCL MARG, FACE 2.1-3 $822.23 $822.23 $822.23 11644 EXCISE,MALG LESION INCL MARG, FACE 3.1-4 $822.23 $822.23 $822.23 11646 EXCISE,MALG LESION INCL MARG,FACE > 4 CM $822.23 $822.23 $822.23 11720 DEBRID NAILS/ANY METHOD(S);ONE TO FIVE $293.65 $293.65 $293.65 11721 DEBRID NAILS BY ANY METHOD(S); 6 OR MORE $293.65 $293.65 $293.65 11730 EXC AVULSIO NAIL PLAPART COM SIMP SINGLE $822.23 $822.23 $822.23 11740 EVACUATION SUBUNGWAL HEMATOMA $822.23 $822.23 $822.23 11750 EXC OF NAIL & NAIL MATRIX $822.23 $822.23 $822.23 11752 EXCIS NAIL/MATX PART/COMP W AMPU DIST TU $822.23 $822.23 $822.23 11755 BIOPSY OF NAIL UNIT (SEPARATE PROCEDURE) $822.23 $822.23 $822.23 07/27/12 Page 2 of 90 PROC DESCRIPTION 2010 Rate 2011 Rate 2012 Rate 11760 RECONSTRUCTION NAIL BEO SIMPLE $822.23 $822.23 $822.23 11762 RECONSTRUCTION NAIL BED COMPLICATED $822.23 $822.23 $822.23 11765 WEDGE EXCIS OF SKIN OF NAIL FOLD(IN-GROW $822.23 $822.23 $822.23 11770 EXC PILONIDAL CYST OR SINUS SIMPLE $1,339.05 $1,339.05 $1,339.05 11771 EXC PILONIDAL CYST OR SINUS EXTENSIVE $1,339.05 $1,339.05 $1,339.05 11772 EXC PILONIDAL CYST OR SINUS COMPLICATED $1,339.05 $1,339.05 $1,339.05 11900 INJECT INTRALESIONAL UP TO 7 LESIONS $822.23 $822.23 $822.23 11901 INJECT INTRALESIONAL MO THAN 7 LESIONS $822.23 $822.23 $822.23 11960 INSERTION OF TISSUE EXPANDERS $293.65 $293.65 $293.65 11970 REPLACE TISSUE EXPANDER WITH PERM PROSTH $822.23 $822.23 $822.23 11971 REMOV TISSU EXPANDER(S) WO INSERT PROSTH $293.65 $293.65 $293.65 11981 INSERT NON-BIODEGRADE DRUG DELIV IMPLANT $822.23 $822.23 $822.23 11982 REMOVE NON-BIODEGRADE DRUG DELIV IMPLANT $822.23 $822.23 $822.23 11983 RMOVE/REINSRT NON-BIO DRUG DELIV IMPLANT $822.23 $822.23 $822.23 12001 SIMPLE REPAIR (AREA) 2.5 OR LESS $293.65 $293.65 $293.65 12002 SIMPLE REPAIR (AREA) 2.6 TO 7.5 CM $293.65 $293.65 $293.65 12004 SIMPLE REPAIR (AREA) 7.6 TO 12.5 CM $125.00 $125.00 $125.00 12005 SIMPLE REPAIR (AREA) 12.6 TO 20.0 CM $822.23 $822.23 $822.23 12006 SIMPLE REPAIR (AREA) 20.1 TO 30.0 CM $822.23 $822.23 $822.23 12007 SIMPLE REPAIR WD SCALP ETC OVER 30CM $822.23 $822.23 $822.23 12011 SIMPLE REPAIR (AREA) 2.5 OR LESS $293.65 $293.65 $293.65 12013 SIMPLE REPAIR (AREA) 2.6 TO 5.0 CM $293.65 $293.65 $293.65 12014 SIMPLE REPAIR (AREA) 5.1 TO 7.5 CM $293.65 $293.65 $293.65 12015 SIMPLE REPAIR (AREA) 7.6 TO 12.5 CM $293.65 $293.65 $293.65 12016 SIMPLE REPAIR (AREA) 12.6 TO 20.0 CM $293.65 $293.65 $293.65 12017 SIMPLE REPAIR (AREA) 20.1 TO 30.0 CM $293.65 $293.65 $293.65 12018 SIMPLE REPAIR WD FACE ETC OVER 30CM $293.65 $293.65 $293.65 12020 TREATMENT SUPERFICIAL WOUND DEHISCENCE $293.65 $293.65 $293.65 12021 TREAT SUPERFICIAL WOUND DEHIS CF W/PACKI $293.65 $293.65 $293.65 12031 LAYER CLOSUR(AREA) 2.5 CM OR LESS $293.65 $293.65 $293.65 12032 LAYER CLOSURE(AREA) 2.6 CM TO 7.5 CM $293.65 $293.65 $293.65 12034 LAYER CLOSURE(AREA) 7.6 CM TO 12.5 CM $822.23 $822.23 $822.23 12035 LAYER CLOSURE(AREA) 12.6 CM TO 20.0 CM $822.23 $822.23 $822.23 12036 LAYER CLOSURE(AREA) 20.1 CM TO 30.0 CM $822.23 $822.23 $822.23 12037 LAYER CLOS SCALP/AX/TRUNK/EXTREM OVER 30 $822.23 $822.23 $822.23 12041 LAYER CLOSURE(AREA) 2.5 CM OR LESS $822.23 $822.23 $822.23 12042 LAYER CLOSURE (AREA) 2.6 CM TO 7.5 CM 75 $822.23 $822.23 $822.23 12044 LAYER CLOS (AREA) 7.6 CM TO 12.5 CM $822.23 $822.23 $822.23 12045 LAYER CLOS (AREA) 12.6 CM TO 20.0 CM $822.23 $822.23 $822.23 12046 LAYER CLOSURE (AREA) 20.1 CM TO 30.00 CM $822.23 $822.23 $822.23 12047 LAYER CLOS NEK/HAN/FET/EX GENIT OVER 30C $822.23 $822.23 $822.23 12051 LAYER CLOSURE (AREA) 2.5 CM OR LESS $293.65 $293.65 $293.65
Recommended publications
  • MISSED? Metastatic Spinal Cord Compression NA Quraishi, C Esler ∗ BMJ 342 (7805), 1023-1025
    PUBLICATIONS (ABSTRACTS EXCLUDED) 2014: Metastatic spinal cord compression as a result of the unknown primary tumour. Quraishi NA, Ramoutar D, Sureshkumar D, Manoharan SR, Spencer A, Arealis G, Edwards KL, Boszczyk BM. Eur Spine J. 2014 Apr 2. Trans-oral approach for the management of a C2 neuroblastoma. Salem KM, Visser J, Quraishi NA. Eur Spine J. 2014 Feb 19. Calcified giant thoracic disc herniations: considerations and treatment strategies. Quraishi NA, Khurana A, Tsegaye MM, Boszczyk BM, Mehdian SM. Eur Spine J. 2014 Apr;23 Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival. Varga PP, Szövérfi Z, Fisher CG, Boriani S, Gokaslan ZL, Dekutoski MB, Chou D, Qurais NA, Reynolds JJ, Luzzati A, Williams R, Fehlings MG, Germscheid NM, Lazary A, Rhines LD. Eur Spine J. 2014 Dec 23. Expert's comment concerning Grand Rounds case entitled: "trans-oral approach for the management of a C2 neuroblastoma. (K. M. I. Salem, J. Visser, and N. A. Quraishi).Choi D. Eur Spine J. 2015 Jan;24(1):177-9. Diagnosis and treatment of a rectal-cutaneous fistula: a rare complication of coccygectomy. Behrbalk E, Uri O, Maxwell-Armstrong C, Quraishi NA. Eur Spine J. 2014 Nov 1. A cohort study to evaluate cardiovascular risk of selective and nonselective cyclooxygenase inhibitors (COX-Is) in arthritic patients attending orthopedic department of a tertiary care hospital. Bhosale UA, Quraishi N, Yegnanarayan R, Devasthale D. Niger Med J. 2014 Sep;55(5):417-22. An evidence-based medicine model for rare and often neglected neoplastic conditions. Fisher CG, Goldschlager T, Boriani S, Varga PP, Rhines LD, Fehlings MG, Luzzati A, Dekutoski MB, Reynolds JJ, Chou D, Berven SH, Williams RP, Quraishi NA, Bettegowda C, Gokaslan ZL.
    [Show full text]
  • CMM-314: Hip Surgery-Arthroscopic and Open Procedures Version 1.0.2019
    CLINICAL GUIDELINES CMM-314: Hip Surgery-Arthroscopic and Open Procedures Version 1.0.2019 Clinical guidelines for medical necessity review of speech therapy services. © 2019 eviCore healthcare. All rights reserved. Comprehensive Musculoskeletal Management Guidelines V1.0.2019 CMM-314: Hip Surgery-Arthroscopic and Open Procedures CMM-314.1: Definitions 3 CMM-314.2: General Guidelines 4 CMM-314.3: Indications and Non-Indications 4 CMM-314.4 Experimental, Investigational, or Unproven 6 CMM-314.5: Procedure (CPT®) Codes 7 CMM-314.6: References 10 © 2019 eviCore healthcare. All rights reserved. Page 2 of 13 400 Buckwalter Place Boulevard, Bluffton, SC 29910 • (800) 918-8924 www.eviCore.com Comprehensive Musculoskeletal Management Guidelines V1.0.2019 CMM-314.1: Definitions Femoroacetabular Impingement (FAI) is an anatomical mismatch between the head of the femur and the acetabulum resulting in compression of the labrum or articular cartilage during flexion. The mismatch can arise from subtle morphologic alterations in the anatomy or orientation of the ball-and-socket components (for example, a bony prominence at the head-neck junction or acetabular over-coverage) with articular cartilage damage initially occurring from abutment of the femoral neck against the acetabular rim, typically at the anterosui per or aspect of the acetabulum. Although hip joints can possess the morphologic features of FAI without symptoms, FAI may become pathologic with repetitive movement and/or increased force on the hip joint. High-demand activities may also result in pathologic impingement in hips with normal morphology. s It ha been proposed that impingement with damage to the labrum and/or acetabulum is a causative factor in the development of hip osteoarthritis, and that as many as half of cases currently categorized as primary osteoarthritis may have an etiology of FAI.
    [Show full text]
  • Physicians As Assistants at Surgery: 2016 Update
    Physicians as Assistants at Surgery: 2016 Update Participating Organizations: American College of Surgeons American Academy of Ophthalmology American Academy of Orthopaedic Surgeons American Academy of Otolaryngology – Head and Neck Surgery American Association of Neurological Surgeons American Pediatric Surgical Association American Society of Colon and Rectal Surgeons American Society of Plastic Surgeons American Society of Transplant Surgeons American Urological Association Congress of Neurological Surgeons Society for Surgical Oncology Society for Vascular Surgery Society of American Gastrointestinal Endoscopic Surgeons The American College of Obstetricians and Gynecologists The Society of Thoracic Surgeons Physicians as Assistants at Surgery: 2016 Update INTRODUCTION This is the seventh edition of Physicians as Assistants at Surgery, a study first undertaken in 1994 by the American College of Surgeons and other surgical specialty organizations. The study reviews all procedures listed in the “Surgery” section of the 2016 American Medical Association’s Current Procedural Terminology (CPT TM). Each organization was asked to review new codes since 2013 that are applicable to their specialty and determine whether the operation requires the use of a physician as an assistant at surgery: (1) almost always; (2) almost never; or (3) some of the time. The results of this study are presented in the accompanying report, which is in a table format. This table presents information about the need for a physician as an assistant at surgery. Also, please note that an indication that a physician would “almost never” be needed to assist at surgery for some procedures does NOT imply that a physician is never needed. The decision to request that a physician assist at surgery remains the responsibility of the primary surgeon and, when necessary, should be a payable service.
    [Show full text]
  • Standard Times Report
    Procedure Standard Time as of: 2021-04-06 Site: ACH Procedure Cat: 25 Selected Show Procedures: ALL Duration Procedure Cat / Standard Standard Site Proc Cd Fixed Standard Procedure Description Std BK Skin To Skin/ Total Setup/Teardown Proc Case ANA ACH Anesthesia Awake Intubation ANAWKINTB 10 10 / 10 = 20 30 ACH Anesthesia Block in PACU Pre OR Admission ANABKRR 10 5 / 10 = 15 25 ACH Anesthesia Blood Patch ANABLDPT 10 5 / 5 = 10 20 ACH Anesthesia Epidural Steroid+/-Analgesia Inject SS ANAEPINJ 10 10 / 10 = 20 30 ACH Anesthesia for XRay ANAXRAY 15 10 / 10 = 20 35 ACH Anesthesia Insert Long Line IV<1 Year ANALINE<1 25 15 / 15 = 30 55 ACH Anesthesia Insert Long Line IV>1 Year ANALINE>1 25 15 / 15 = 30 55 ACH Anesthesia Intubate Only OR ANAINTB / = ACH Anesthesia Intubate Only PACU ANAINTBRR 10 5 / 5 = 10 20 ACH Anesthesia Local+/-Regional Block State Type ANABKOR 30 15 / 15 = 30 60 ACH Anesthesia Post Op Readmit to PACU ANARADMRR 10 10 / 10 = 20 30 ACH Anesthesia Pseudocholinesterase Deficiency ANAPSURR 10 10 / 10 = 20 30 ACH Anesthesia Spinal Block ANASPBK 10 10 / 10 = 20 30 ACH Anesthesia Spine Facet Injection ANASPINJ 10 10 / 10 = 20 30 ACH Lumbar Puncture LUPUNC 10 25 / 15 = 40 50 CAR ACH Cardiac Catheterization & Balloon Angioplasty HRCARCBANG 90 20 / 20 = 40 130 ACH Cardiac Catheterization w Full Biopsy HRCARCBX 90 40 / 30 = 70 160 ACH Cardiac Catheterization w Partial Biopsy HRCARCBXP 40 20 / 20 = 40 80 ACH Cardiac Catheterization+/-Valvoplasty HRCARCVL 90 40 / 30 = 70 160 ACH Catheter Insertion Aphoresis CAINAPHP 20 15 / 10 = 25 45
    [Show full text]
  • Decellularized Tissue Engineered Constructs Using Cell Sheet Technology
    Decellularized Tissue Engineered Constructs Using Cell Sheet Technology Author Farag, Amro Ahmed Mahmoud Published 2016 Thesis Type Thesis (PhD Doctorate) School School of Dentistry and Oral Health DOI https://doi.org/10.25904/1912/2310 Copyright Statement The author owns the copyright in this thesis, unless stated otherwise. Downloaded from http://hdl.handle.net/10072/367720 Griffith Research Online https://research-repository.griffith.edu.au Decellularized Tissue engineered constructs using cell sheet technology Amro Ahmed Mahmoud Farag BDSc, M.Sc. (Periodontics) School of Dentistry Griffith Health Griffith University Submitted in fulfilment of the requirements of the degree of Doctor of Philosophy 3/30/2016 I Statement of Originality I, Amro Farag declare that this work has not previously been submitted for a degree or diploma in any university. To the best of my knowledge and belief, the thesis contains no material previously published or written by another person except where due reference is made in the thesis itself. (Signed)_____________________________ Amro Farag II Contents Statement of Originality ......................................................................................... II Contents ............................................................................................................... III List of Tables ..................................................................................................... VIII List of Figures.....................................................................................................
    [Show full text]
  • 682-8137 Or [email protected] NASS Releases Must-Have
    FOR IMMEDIATE RELEASE Contact: Nicolle Heller, NASS October 7, 2015 (773) 682-8137 or [email protected] NASS Releases Must-Have Tool for Spine Specialists: eBook of Coverage Policy Recommendations --Subscription is Free to All NASS Members-- Burr Ridge, IL—In a game-changing move for patients and spine specialists, the North American Spine Society (NASS) unveiled its latest resource, the NASS Coverage Policy Recommendations eBook. An annual subscription to this online book of NASS coverage guidance on common spine treatments is free to all NASS members and available for purchase by non-members. “Spine specialists spend a great deal of time—time they could be spending caring for their patients—doing labor-intensive research, filling out onerous paperwork and participating in peer-to-peer reviews to justify even common treatments to payers,” said Christopher M. Bono, MD, NASS First Vice-President and the first Coverage Committee Chair. “This essential eBook of evidence-based recommendations will help them navigate this system and get their patients the care they need to quickly get back to enjoying active, productive lives.” NASS Coverage Policy Recommendations is a 100+ page online, searchable book that includes NASS’ current 17 coverage recommendations, extensive citations, active links to published research and interactive elements such as video. NASS will add recommendations and revise existing recommendations periodically based on the availability of new evidence-based literature and the feedback it receives from members, patients and insurance entities. Subscribers automatically will have access to the most recent edition online. To develop each published recommendation, the multi-disciplinary NASS Coverage Committee conducts an extensive review of available scientific literature.
    [Show full text]
  • Products of Ambulatory Surgery 2008 Procedure Codes
    Products of Ambulatory Surgery 2008 Procedure Codes CPT Begin /HCPCS CPT Description PAS PAS Description Date 28035 Release, tarsal tunnel (posterior tibial nerve decompression) 1 Nerve Repair 2/1/2004 28080 Excision, interdigital (Morton) neuroma, single, each 1 Nerve Repair 2/1/2004 61790 Creation of lesion by stereotactic method, percutaneous, by neurolytic agent (eg, alcohol, thermal, electrical, radiofrequency); gasserian ganglion 1 Nerve Repair 2/1/2004 Insertion or replacement of cranial neurostimulator pulse generator or receiver, direct or inductive coupling; with connection to a single electrode 61885 array 1 Nerve Repair 2/1/2004 InIncisioncision aandnd subcutasubcutaneousneous pplacementlacement ooff ccranialranial nneurostimulatoreurostimulator pupulselse gegeneratornerator oorr rreceiver,eceiver, ddirectirect oorr ininductiveductive coupcoupling;ling; wiwithth coconnectionnnection to ttwowo oorr 61886 more electrode arrays 1 Nerve Repair 2/1/2004 62268 Percutaneous aspiration, spinal cord cyst or syrinx 1 Nerve Repair 2/1/2004 62269 Biopsy of spinal cord, percutaneous needle 1 Nerve Repair 2/1/2004 62270 Spinal puncture, lumbar, diagnostic 1 Nerve Repair 2/1/2004 62272 Spinal puncture, therapeutic, for drainage of cerebrospinal fluid (by needle or catheter) 1 Nerve Repair 2/1/2004 62273 Injection, epidural, of blood or clot patch 1 Nerve Repair 2/1/2004 62280 Injection/infusion of neurolytic substance (eg, alcohol, phenol, iced saline solutions), with or without other therapeutic substance; subarachnoid 1 Nerve Repair 2/1/2004
    [Show full text]
  • SJH Procedures
    SJH Procedures - Orthopedics and Podiatry Service New Name Old Name CPT Code Service ABLATION, PLANTAR WART, USING CO2 LASER LASER VAPORIZATION (WARTS/LESIONS) PLANTAR FOOT W CO2 LASER 17110 Destruction (eg, laser surgery, electrosurgery, cryosurgery, Podiatry chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions ACROMIOPLASTY, ARTHROSCOPIC, WITH DISTAL CLAVICLE EXCISION ARTHROSCOPY DISTAL CLAVICLE ACROMIOPLASTY/REPAIR/EXCISION 29824 Arthroscopy, shoulder, surgical; distal claviculectomy including Orthopedics distal articular surface (Mumford procedure) 29826 Arthroscopy, shoulder, surgical; decompression of subacromial Orthopedics space with partial acromioplasty, with coracoacromial ligament (ie, arch) release, when performed (List separately in addition to code for primary procedure) ALLOGRAFT, OSTEOCHONDRAL, KNEE, OPEN OSTEOCHONDRAL ALLOGRAFT TRANSPLANTATION OPEN KNEE 27415 Osteochondral allograft, knee, open Orthopedics AMPUTATION, BELOW KNEE AMPUTATION LEG BELOW KNEE *27880 Amputation, leg, through tibia and fibula; Vascular, Orthopedics *27881 Amputation, leg, through tibia and fibula; with immediate Vascular, Orthopedics fitting technique including application of first cast *27882 Amputation, leg, through tibia and fibula; open, circular Vascular, Orthopedics (guillotine) *27886 Amputation, leg, through tibia and fibula; re-amputation Vascular, Orthopedics AMPUTATION, FINGER AMPUTATION FINGER 26910 Amputation, metacarpal, with finger or thumb (ray
    [Show full text]
  • RGH Procedure Cat: 25 Selected Show Procedures: ALL
    Procedure Standard Time as of: 2021-04-06 Site: RGH Procedure Cat: 25 Selected Show Procedures: ALL Duration Procedure Cat / Standard Standard Site Proc Cd Fixed Standard Procedure Description Std BK Skin To Skin/ Total Setup/Teardown Proc Case ANA RGH Anesthesia Awake Intubation ANAWKINTB 10 10 / 10 = 20 30 RGH Anesthesia Block in PACU Pre OR Admission ANABKRR 10 5 / 10 = 15 25 RGH Anesthesia Blood Patch ANABLDPT 10 5 / 5 = 10 20 RGH Anesthesia Epidural Steroid+/-Analgesia Inject SS ANAEPINJ 10 10 / 10 = 20 30 RGH Anesthesia for XRay ANAXRAY 15 10 / 10 = 20 35 RGH Anesthesia Insert Long Line IV<1 Year ANALINE<1 0 0 / 0 = 0 0 RGH Anesthesia Insert Long Line IV>1 Year ANALINE>1 10 10 / 10 = 20 30 RGH Anesthesia Intubate Only OR ANAINTB 15 10 / 10 = 20 35 RGH Anesthesia Intubate Only PACU ANAINTBRR 10 5 / 5 = 10 20 RGH Anesthesia Local+/-Regional Block State Type ANABKOR 30 15 / 15 = 30 60 RGH Anesthesia Post Op Readmit to PACU ANARADMRR 10 10 / 10 = 20 30 RGH Anesthesia Pseudocholinesterase Deficiency ANAPSURR 10 10 / 10 = 20 30 RGH Anesthesia Spinal Block ANASPBK 10 10 / 10 = 20 30 RGH Anesthesia Spine Facet Injection ANASPINJ 10 10 / 10 = 20 30 RGH Lumbar Puncture LUPUNC 5 15 / 10 = 25 30 CAR RGH Cardiac Catheterization & Balloon Angioplasty HRCARCBANG 0 0 / 0 = 0 0 RGH Cardiac Catheterization w Full Biopsy HRCARCBX / = RGH Cardiac Catheterization w Partial Biopsy HRCARCBXP / = RGH Cardiac Catheterization+/-Valvoplasty HRCARCVL / = RGH Catheter Insertion Aphoresis CAINAPHP 0 0 / 0 = 0 0 RGH Heart Cardioversion HRCARDVS 15 15 / 15 = 30
    [Show full text]
  • Reimbursement Efforts at Nass Areas of Focus for Nass
    2/21/2018 EMERGING ISSUES IN REIMBURSEMENT EFFORTS FOR SPINE PROCEDURES ERIC J. MUEHLBAUER, MJ, CAE CEO, NASS A BEHIND THE SCENES LOOK REIMBURSEMENT EFFORTS AT NASS AREAS OF FOCUS FOR NASS Coverage Recommendations Payor Policy Reviews CPT and RUC 1 2/21/2018 COVERAGE COMMITTEE - MISSION Develop credible and reasonable coverage recommendations for spine care by proactively reviewing and incorporating existing NASS policy comments and Evidence-based Medicine guidelines to educate physicians and payors on fair coverage decisions. Health Policy Strategic Plan 2014 Too many policy reviews to do If we were an insurance company what would we have as a policy? Evidence informed, not necessarily dictated. Guidelines “insufficient evidence” = punt Coverage Recommendations = What is Reasonable? COVERAGE COMMITTEE Co- Chairs: Gary Ghiselli, MD, Orthopedic Surgeon Scott Kreiner, MD, Physiatry 32 members (EMB training is required) 15 Orthopedic Surgeons 9 Physiatrists 6 Neurosurgeons 2 Anesthesiologists. COVERAGE RECOMMENDATIONS - PROCESS 5-6 month process 1. Topics Generated a. Committee works to generate list of topics: Email to NASS Health Policy team, Payer Policy Review Committee, Coverage Committee, Board b. Topics are sent to Coverage Committee members who rank top 3 c. Priority list is sent to co-chairs who assign authors to topics d. Assignment list is sent to members. 2 2/21/2018 ONCE TOPIC IS ASSIGNED 2. Literature search is conducted a. Lit Search Request Form is sent to medical librarian. b. Abstract results are sent to the author who highlights the articles they want. 3. Article retrieval a. Once all articles have been retrieved, staff liaison notifies author that articles can be accessed via our system.
    [Show full text]
  • Resection of the Coccyx As an Outpatient Procedure
    Orthopedic Reviews 2020; volume 12:8813 Resection of the coccyx as an treatment and injection therapy have failed outpatient procedure patients can be treated surgically with Correspondence: Ante M. Kalstad, coccygectomy.1,2 Department of Orthopaedic Surgery, St. Traditionally, coccygectomy patients Olav’s University Hospital, 7006 Trondheim, 1-3 Ante M. Kalstad, spend several days in hospital after their Norway. 1 Tel.: +47 90888107 Rainer G. Knobloch, operation. In the 1990s, the average stay 1,3 E-mail: [email protected] Vilhjalmur Finsen after this procedure was 7-10 days.3 1Department of Orthopaedic Surgery, Outpatient surgery (also known as day Key words: Coccyx; tailbone; coccygectomy; St. Olav’s University Hospital, surgery, same-day surgery or ambulatory outpatient surgery; ambulatory surgery. Trondheim; 2Norwegian Armed Forces surgery) refers to surgical procedures that are Funding: None. Joint Medical Services; 3Faculty of performed without staying overnight in the hospital. Following advances in peri- and Medicine, Norwegian University of Conflict of interest: The authors declare no postoperative pain control regimens and Science and Technology, NTNU, conflicts of interest. early rehabilitation protocols there has been Trondheim, Norway a trend in other areas of surgery towards Ethics approval: The study protocol was performing more outpatient procedures. In reviewed by the Regional committee for med- recent years, this has included procedures ical and health research ethics in Central such as unicompartmental knee arthroplasty, Norway (2016/460) who found that it did not Abstract and even total hip arthroplasty,4 commonly need their approval. regarded as an inpatient procedure. This We wished to determine if Availability of data and materials: Data and coccygectomy as an outpatient procedure is development has the benefit of reducing materials are available in the main text.
    [Show full text]
  • Hip Surgery – Arthroscopic and Open Procedures
    CLINICAL GUIDELINES CMM-314 ~ Hip Surgery – Arthroscopic and Open Procedures Version 19.0 Effective August 11, 2017 eviCore healthcare Clinical Decision Support Tool Diagnostic Strategies:This tool addresses common symptoms and symptom complexes. Imaging requests for individuals with atypical symptoms or clinical presentations that are not specifically addressed will require physician review. Consultation with the referring physician, specialist and/or individual’s Primary Care Physician (PCP) may provide additional insight. CPT® (Current Procedural Terminology) is a registered trademark of the American Medical Association (AMA). CPT® five digit codes, nomenclature and other data are copyright 2016 American Medical Association. All Rights Reserved. No fee schedules, basic units, relative values or related listings are included in the CPT® book. AMA does not directly or indirectly practice medicine or dispense medical services. AMA assumes no liability for the data contained herein or not contained herein. © 2017 eviCore healthcare. All rights reserved. CMM-314~ Hip Surgery-Arthroscopic and Open Procedures CMM-314.1: Definitions 3 CMM-314.2: General Guidelines 3 CMM-314.3: Indications and Non-Indications 4 CMM-314.4: Procedure (CPT®) Codes 5 CMM-314.5: References 8 Page 2 of 10 CMM-314: Hip Surgery-Arthroscopic and Open Procedures CMM-314.1: Definitions Femoroacetabular Impingement (FAI) is a condition that has been recently recognized, is an anatomical mismatch between the head of the femur and the acetabulum resulting in compression of the labrum or articular cartilage during flexion. The mismatch can arise from subtle morphologic alterations in the anatomy or orientation of the ball-and-socket components (for example, a bony prominence at the head-neck junction or acetabular over coverage) with articular cartilage damage initially occurring from abutment of the femoral neck against the acetabular rim, typically at the anterosuperior aspect of the acetabulum.
    [Show full text]